Calpain and other cytosolic proteases can contribute to the degradation of retro-translocated prion protein in the cytosol

被引:29
作者
Wang, XH
Wang, F
Sy, MS
Ma, JY [1 ]
机构
[1] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA
[2] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA
关键词
D O I
10.1074/jbc.M410649200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PrP, a cell surface-localized N-linked glycoprotein, is required for the pathogenesis of prion diseases. Recent studies have revealed that prion protein ( PrP) becomes neurotoxic and prone to aggregation when it is in the cytosol, suggesting that cytosolic PrP may play a role in the pathogenesis of prion disease. Retro-translocation of PrP from the endoplasmic reticulum to the cytosol for proteasome degradation offers a natural route for PrP to enter the cytosol, but whether PrP is subject to retro-translocation is controversial. In this study, we investigated the metabolism of endogenous wild-type PrP in several cell lines and in primary mouse cortical neurons. Our results suggest that a portion of the endogenous wild-type PrP is retro-translocated to the cytosol and degraded by the proteasome. Moreover, we also found that calpain and other cytosolic proteases could degrade PrP in the cytosol when the proteasome activity is compromised. These results provide the foundation for the hypothesis that cytosolic PrP may be involved in the pathogenesis of prion disease.
引用
收藏
页码:317 / 325
页数:9
相关论文
共 53 条
  • [1] Recent advances in prion biology
    Aguzzi, A
    Miele, G
    [J]. CURRENT OPINION IN NEUROLOGY, 2004, 17 (03) : 337 - 342
  • [2] Prion diseases - Cannibals and garbage piles
    Aguzzi, A
    Heikenwalder, M
    [J]. NATURE, 2003, 423 (6936) : 127 - 129
  • [3] BORCHELT DR, 1992, J BIOL CHEM, V267, P16188
  • [4] Normal host prion protein necessary for scrapie-induced neurotoxicity
    Brandner, S
    Isenmann, S
    Raeber, A
    Fischer, M
    Sailer, A
    Kobayashi, Y
    Marino, S
    Weissmann, C
    Aguzzi, A
    [J]. NATURE, 1996, 379 (6563) : 339 - 343
  • [5] PRION PROTEIN-BIOSYNTHESIS IN SCRAPIE-INFECTED AND UNINFECTED NEURO-BLASTOMA CELLS
    CAUGHEY, B
    RACE, RE
    ERNST, D
    BUCHMEIER, MJ
    CHESEBRO, B
    [J]. JOURNAL OF VIROLOGY, 1989, 63 (01) : 175 - 181
  • [6] Prion protein and the transmissible spongiform encephalopathies
    Caughey, B
    Chesebro, B
    [J]. TRENDS IN CELL BIOLOGY, 1997, 7 (02) : 56 - 62
  • [7] CHESEBRO B, 1993, DEV BIOL STAND, V80, P131
  • [8] Prion diseases: What is the neurotoxic molecule?
    Chiesa, R
    Harris, DA
    [J]. NEUROBIOLOGY OF DISEASE, 2001, 8 (05) : 743 - 763
  • [9] Neurological illness in transgenic mice expressing a prion protein with an insertional mutation
    Chiesa, R
    Piccardo, P
    Ghetti, B
    Harris, DA
    [J]. NEURON, 1998, 21 (06) : 1339 - 1351
  • [10] Prion diseases of humans and animals: Their causes and molecular basis
    Collinge, J
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 2001, 24 : 519 - 550